[1] Zhang ZB, Sun P, Liu JW, Fu L, Yan J, Liu YJ, Yu LH, Wang XQ, Yan Q. Suppression of FUT1/FUT4 expression by siRNA inhibits tumor growth. Biochim Biophys Acta , 2008, 1783(2): 287-296. [2] Dettke M, Pálfi G, Pursch E, Fischer MB, Loibner H. Increased expression of the blood group-related Lewis Y antigen on synovial fluid granulocytes of patients with arthritic joint diseases. Rheumatology (Oxford), 2001, 40(9): 1033-1037. [3] Ponnampalam AP, Rogers PAW. Expression and regulation of fucosyltransferase 4 in human endometrium. Reproduction , 2008, 136(1): 117-123. [4] Ciolczyk-Wierzbicka D, Bodzioch M, Gil D, Zmudzińska D, Dembińska-Kiec A, Laidler P. Expression of fucosyltransferases contributes to melanoma invasive phenotype. Med Chem , 2007, 3(5): 418-424. [5] Escrevente C, Machado E, Brito C, Reis CA, Stoeck A, Runz S, Marmé A, Altevogt P, Costa J. Different expression levels of alpha3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell lines. Int J Oncol , 2006, 29(3): 557-566. [6] Kudo T, Ikehara Y, Togayachi A, Morozumi K, Watanabe M, Nakamura M, Nishihara S, Narimatsu H. Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Lab Invest , 1998, 78(7): 797-811. [7] Martín-Satué M, Marrugat R, Cancelas JA, Blanco J. Enhanced expression of alpha(1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells. Cancer Res , 1998, 58(7): 1544-1550. [8] Petretti T, Schulze B, Schlag PM, Kemmner W. Altered mRNA expression of glycosyltransferases in human gastric carcinomas. Biochim Biophys Acta , 1999, 1428(2-3): 209-218. [9] Yang XS, Zhang ZB, Jia S, Liu YJ, Wang XQ, Yan Q. Overexpression of fucosyltransferase IV in A431 cell line increases cell proliferation. Int J Biochem Cell Biol , 2007, 39(9): 1722-1730. [10] Yang XS, Liu S, Liu YJ, Liu JW, Liu TJ, Wang XQ, Yan Q. Overexpression of fucosyltransferase IV promotes A431 cell proliferation through activating MAPK and PI3K/Akt signaling pathways. J Cell Physiol , 2010, 225(2): 612-619. [11] Terracciano D, Di Carlo A, Papa P, Cicalese M, Maietta P, Cecere C, Mariano A, Macchia V. New approaches in the diagnostic procedure of malignant pleural effusions. Oncol Rep , 2004, 12(1): 79-83. [12] Di Carlo A, Terracciano D, Mariano A, Oliva A, D'Armiento M, Macchia V. Role of cytokeratins, nuclear matrix proteins, Lewis antigen and epidermal growth factor receptor in human bladder tumors. Int J Oncol , 2003, 23(3): 757-762. [13] Farhan H, Schuster C, Klinger M, Weisz E, Waxenecker G, Schuster M, Sexl V, Mudde GC, Freissmuth M, Kircheis R. Inhibition of xenograft tumor growth and down-regulation of ErbB receptors by an antibody directed against Lewis Y antigen. J Pharmacol Exp Ther , 2006, 319(3): 1459-1466. [14] Boghaert ER, Sridharan L, Armellino DC, Khandke KM, DiJoseph JF, Kunz A, Dougher MM, Jiang F, Kalyandrug LB, Hamann PR, Frost P, Damle NK. Antibody-targeted chemotherapy with the calicheamicin conjugate hu3S193-N-acetyl γcalicheamicin dimethyl hydrazide targets Lewis y and eliminates Lewis y -positive human carcinoma cells and xenografts. Clin Cancer Res , 2004, 10(13): 4538-4549. [15] Li HY, Tong SM, Liu JW, Han L, Yang XS, Hou HS, Yan Q, Wang XQ. Differential fucosyltransferase IV expression in Squamous carcinoma cells is regulated by promoter methylation. Cell Mol Biol Lett , 2012, 17(2): 206-216. [16] Taniguchi A, Suga R, Matsumoto K. Expression and transcriptional regulation of the human alpha1, 3-fucosyltransferase 4 (FUT4) gene in myeloid and colon adenocarcinoma cell lines. Biochem Biophys Res Commun , 2000, 273(1): 370-376. [17] Yang XS, Wang J, Liu S, Yan Q. HSF1 and Sp1 regulate FUT4 gene expression and cell proliferation in breast cancer cells. J Cell Biochem , 2014, 115(1): 168-178. [18] Withers DA, Hakomori SI. Human alpha (1,3)-fucosyltransferase IV (FUTIV) gene expression is regulated by elk-1 in the U937 cell line. J Biol Chem , 2000, 275(51): 40588-40593. [19] Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res , 2003, 63(3): 664-673. [20] Wu HJ, Chen YP, Liang J, Shi B, Wu G, Zhang Y, Wang D, Li RF, Yi X, Zhang H, Sun LY, Shang YF. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature , 2005, 438(7070): 981-987. [21] Kang CW, Song JJ, Lee J, Kim MY. Epigenetics: An emerging player in gastric cancer. World J Gastroenterol , 2014, 20(21): 6433-6447. [22] Zhang GQ, Pradhan S. Mammalian epigenetic mechanisms. IUBMB Life , 2014, 66(4): 240-256. [23] Huang B, Jiang C, Zhang R. Epigenetics: the language of the cell? Epigenomics , 2014, 6(1): 73-88. [24] Jeltsch A, Jurkowska RZ. New concepts in DNA methylation. Trends Biochem Sci , 2014, 39(7): 310-318. [25] Serpa J, Mesquita P, Mendes N, Oliveira C, Almeida R, Santos-Silva F, Reis CA, LePendu J, David L. Expression of Lea in gastric cancer cell lines depends on FUT3 expression regulated by promoter methylation. Cancer Lett , 2006, 242(2): 191-197. [26] Syrbe U, Jennrich S, Schottelius A, Richter A, Radbruch A, Hamann A. Differential regulation of P-selectin ligand expression in naive versus memory CD4+ T cells: evidence for epigenetic regulation of involved glycosyltransferase genes. Blood , 2004, 104(10): 3243-3248. [27] Yang XS, Liu S, Yan Q. Role of fucosyltransferase IV in epithelial-mesenchymal transition in breast cancer cells. Cell Death Dis , 2013, 4(7): e735. [28] Zhu WG, Srinivasan K, Dai ZY, Duan WR, Druhan LJ, Ding HM, Yee L, Villalona-Calero MA, Plass C, Otterson GA. Methylation of adjacent CpG sites affects Sp1/ Sp3 binding and activity in the p21Cip1 promoter. Mol Cell Biol , 2003, 23(12): 4056-4065. [29] Zhang Y, Fatima N, Dufau ML. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Mol Cell Biol , 2005, 25(18): 7929-7939. |